Chemed (NYSE:CHE) Announces Quarterly Earnings Results, Misses Estimates By $0.12 EPS

Chemed (NYSE:CHE) issued its quarterly earnings data on Tuesday. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12), Briefing.com reports. The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business posted $5.32 EPS. Chemed updated its FY24 guidance to $23.00-$23.15 EPS and its FY 2024 guidance to 23.000-23.150 EPS.

Chemed Trading Down 0.9 %

Shares of CHE traded down $4.66 during mid-day trading on Friday, hitting $535.58. 102,188 shares of the company’s stock were exchanged, compared to its average volume of 84,744. Chemed has a fifty-two week low of $525.36 and a fifty-two week high of $654.62. The firm has a market capitalization of $8.06 billion, a P/E ratio of 27.32, a P/E/G ratio of 2.18 and a beta of 0.44. The business’s 50 day moving average is $586.09 and its two-hundred day moving average is $568.84.

Insider Activity at Chemed

In other news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares in the company, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at $62,117,555.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,144 shares of company stock worth $4,141,679 over the last 90 days. Company insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.